Travoprost Ophthalmic Solution, 0.004%

Mylan Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Jan 15, 2026
Approval ID: 00dc284f-fd96-423b-bb8f-b90ee13439bf
Products: 1 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TRAVOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for TRAVOPROST OPHTHALMIC SOLUTION. TRAVOPROST ophthalmic solution (ionic buffered solution) 0.004%, for topical ophthalmic useInitial U.S. Approval: 2001

Quick Stats

Total Products1

Labelers2

Label Sections29

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.